Sign inGet started

KIM DENNIS D

Insider CIK 1456750 · CBAY Chief Medical Officer · ZFGN Chief Medical Officer · EMBI Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CBAY CymaBay Therapeutics, Inc. M Exercise deriv2023-04-172023-04-17112,219— $0169,900SEC↗
CBAY CymaBay Therapeutics, Inc. M Exercise2023-04-172023-04-17112,219$4.37 $490.4K132,219SEC↗
CBAY CymaBay Therapeutics, Inc. S Sale2023-04-172023-04-17112,219$9.54 $1.07M20,000SEC↗
CBAY CymaBay Therapeutics, Inc. M Exercise deriv2023-04-132023-04-177,781— $0282,119SEC↗
CBAY CymaBay Therapeutics, Inc. M Exercise2023-04-132023-04-177,781$4.37 $34.0K27,781SEC↗
CBAY CymaBay Therapeutics, Inc. S Sale2023-04-132023-04-177,781$8.98 $69.9K20,000SEC↗
CBAY CymaBay Therapeutics, Inc. M Exercise deriv2023-03-282023-03-30100— $0289,900SEC↗
CBAY CymaBay Therapeutics, Inc. M Exercise2023-03-282023-03-30100$4.37 $43720,100SEC↗
CBAY CymaBay Therapeutics, Inc. S Sale2023-03-282023-03-30100$8.99 $89920,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2023-01-252023-01-27180,000— $0180,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2022-01-252022-01-27133,333— $0133,333SEC↗
CBAY CymaBay Therapeutics, Inc. P Buy2022-01-192022-01-2020,000$3.04 $60.8K20,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2021-05-172021-05-17390,000— $0390,000SEC↗
CBAY CymaBay Therapeutics, Inc. A Award deriv2021-05-172021-05-1710,000— $010,000SEC↗
EMBI Emerald Bioscience, Inc. A Award deriv2020-08-072020-08-114,000,000— $04,736,541SEC↗
EMBI Emerald Bioscience, Inc. A Award deriv2019-08-212019-08-23736,541— $0736,541SEC↗
ZFGN ZAFGEN, INC. A Award deriv2019-01-222019-01-2495,000— $095,000SEC↗
ZFGN ZAFGEN, INC. A Award deriv2018-02-222018-02-23125,000— $0125,000SEC↗
ZFGN ZAFGEN, INC. P Buy2017-07-112017-07-1210,000$3.39 $33.9K21,443SEC↗
ZFGN ZAFGEN, INC. P Buy2017-05-112017-05-119,800$4.40 $43.1K11,443SEC↗
ZFGN ZAFGEN, INC. P Buy2017-05-102017-05-11200$4.40 $8801,643SEC↗
ZFGN ZAFGEN, INC. A Award deriv2017-01-272017-01-3188,000— $088,000SEC↗
ZFGN ZAFGEN, INC. A Award deriv2016-03-312016-04-0475,000— $075,000SEC↗
ZFGN ZAFGEN, INC. A Award deriv2016-03-312016-04-0437,500— $037,500SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-172015-10-209,142$40.00 $365.7K0SEC↗
ZFGN ZAFGEN, INC. M Exercise deriv2015-09-172015-09-179,142— $0103,312SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-172015-09-179,142$40.00 $365.7K0SEC↗
ZFGN ZAFGEN, INC. M Exercise2015-09-172015-09-179,142$1.57 $14.4K9,142SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-152015-10-2030,265$40.00 $1.21M0SEC↗
ZFGN ZAFGEN, INC. M Exercise deriv2015-09-152015-09-1730,265— $0112,454SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-152015-09-1730,265$40.00 $1.21M0SEC↗
ZFGN ZAFGEN, INC. M Exercise2015-09-152015-09-1730,265$1.57 $47.5K30,265SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-142015-10-20593$40.00 $23.7K0SEC↗
ZFGN ZAFGEN, INC. M Exercise deriv2015-09-142015-09-16593— $0142,719SEC↗
ZFGN ZAFGEN, INC. S Sale2015-09-142015-09-16593$40.00 $23.7K0SEC↗
ZFGN ZAFGEN, INC. M Exercise2015-09-142015-09-16593$1.57 $931593SEC↗
ZFGN ZAFGEN, INC. A Award deriv2015-02-272015-03-0390,000— $0281,509SEC↗